LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 3.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $497,336 | -19.8% | 8,300 | -3.5% | 0.01% | -21.4% |
Q2 2023 | $620,060 | +12.4% | 8,600 | +14.7% | 0.01% | 0.0% |
Q1 2023 | $551,700 | +108502.4% | 7,500 | -1.3% | 0.01% | 0.0% |
Q4 2022 | $508 | -99.9% | 7,600 | -1.3% | 0.01% | -26.3% |
Q3 2022 | $663,000 | -13.3% | 7,700 | -6.1% | 0.02% | -5.0% |
Q2 2022 | $765,000 | -8.1% | 8,200 | +1.2% | 0.02% | 0.0% |
Q1 2022 | $832,000 | -33.5% | 8,100 | 0.0% | 0.02% | -25.9% |
Q4 2021 | $1,251,000 | +12.2% | 8,100 | +1.2% | 0.03% | 0.0% |
Q3 2021 | $1,115,000 | +97.7% | 8,000 | +86.0% | 0.03% | +92.9% |
Q2 2021 | $564,000 | -14.0% | 4,300 | 0.0% | 0.01% | -17.6% |
Q1 2021 | $656,000 | +64.8% | 4,300 | +7.5% | 0.02% | +41.7% |
Q4 2020 | $398,000 | +4.5% | 4,000 | 0.0% | 0.01% | -33.3% |
Q3 2020 | $381,000 | -14.8% | 4,000 | 0.0% | 0.02% | -33.3% |
Q2 2020 | $447,000 | +53.6% | 4,000 | 0.0% | 0.03% | +28.6% |
Q1 2020 | $291,000 | -33.6% | 4,000 | -4.8% | 0.02% | -4.5% |
Q4 2019 | $438,000 | -4.4% | 4,200 | -8.7% | 0.02% | -8.3% |
Q3 2019 | $458,000 | -21.0% | 4,600 | -8.0% | 0.02% | -17.2% |
Q2 2019 | $580,000 | -16.1% | 5,000 | -9.1% | 0.03% | -14.7% |
Q1 2019 | $691,000 | -9.1% | 5,500 | -1.8% | 0.03% | -20.9% |
Q4 2018 | $760,000 | -70.2% | 5,600 | -39.8% | 0.04% | -60.6% |
Q3 2018 | $2,553,000 | +29.7% | 9,300 | -2.1% | 0.11% | +22.5% |
Q2 2018 | $1,968,000 | +26.7% | 9,500 | +1.1% | 0.09% | +25.4% |
Q1 2018 | $1,553,000 | +24.6% | 9,400 | +3.3% | 0.07% | +24.6% |
Q4 2017 | $1,246,000 | +7.7% | 9,100 | +7.1% | 0.06% | +5.6% |
Q3 2017 | $1,157,000 | +22.2% | 8,500 | +9.0% | 0.05% | +17.4% |
Q2 2017 | $947,000 | +16.2% | 7,800 | +1.3% | 0.05% | +12.2% |
Q1 2017 | $815,000 | +5.6% | 7,700 | +1.3% | 0.04% | +2.5% |
Q4 2016 | $772,000 | -9.9% | 7,600 | -9.5% | 0.04% | -11.1% |
Q3 2016 | $857,000 | -14.5% | 8,400 | 0.0% | 0.04% | -15.1% |
Q2 2016 | $1,002,000 | +16.9% | 8,400 | +5.0% | 0.05% | +17.8% |
Q1 2016 | $857,000 | -1.2% | 8,000 | 0.0% | 0.04% | +2.3% |
Q4 2015 | $867,000 | +26.6% | 8,000 | 0.0% | 0.04% | +25.7% |
Q3 2015 | $685,000 | -14.1% | 8,000 | +1.3% | 0.04% | -7.9% |
Q2 2015 | $797,000 | +32.6% | 7,900 | +1.3% | 0.04% | +31.0% |
Q1 2015 | $601,000 | +33.0% | 7,800 | -8.2% | 0.03% | +38.1% |
Q4 2014 | $452,000 | +10.5% | 8,500 | -2.3% | 0.02% | +5.0% |
Q3 2014 | $409,000 | -31.6% | 8,700 | -9.4% | 0.02% | -28.6% |
Q2 2014 | $598,000 | -7.4% | 9,600 | 0.0% | 0.03% | -9.7% |
Q1 2014 | $646,000 | +30.8% | 9,600 | +2.1% | 0.03% | +34.8% |
Q4 2013 | $494,000 | – | 9,400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |